Leon Cooperman takes $180 million GPGI position with stock still down 20% from June
14 August 2026

Leon Cooperman takes $180 million GPGI position with stock still down 20% from June

NEW YORK, August 14, 2026, 11:46 EDT — Leon Cooperman has disclosed a $180 million investment in GPGI, with the company’s shares continuing to trade 20% below their June level.

  • As of June 30, Leon Cooperman reported holding 11.38 million GPGI shares valued at $180.4 million.
  • This holding marked his biggest new investment and was the fifth-largest in the $3.55 billion portfolio.
  • GPGI closed at $12.69 on Friday, roughly 20% under the quarter-end implied price reported in the filing.

On Friday, Leon Cooperman reported a fresh $180.4 million position in GPGI Inc. , marking his largest new investment in the second quarter. Cooperman held 11,384,508 shares as of June 30.

The stated figure suggests a $15.85 price at quarter’s close. GPGI shares stood at $12.69 as of 11:41 a.m. EDT on Friday, falling 1.8% for the session. Based on that value, Cooperman’s reported holding was approximately $144.5 million—$36.0 million less than the figure recorded in June.

The filing does not specify the timing of his acquisition. It also leaves out the amount he paid. As a result, investors cannot assume the $36 million difference represents Cooperman’s loss.

GPGI represented 5.1% of Cooperman’s $3.547 billion U.S. equity holdings. The portfolio increased by 16.4%, rising from $3.048 billion in March. The disclosed number of positions dropped to 39 from 41.

Top June 30 holdingSharesReported valuePortfolio weight
Vertiv Holdings 2.16 million$722.5 million20.4%
Rocket Companies 21.02 million$331.0 million9.3%
Energy Transfer 13.32 million$254.7 million7.2%
Pelagos Insurance Capital8.51 million$207.3 million5.8%
GPGI 11.38 million$180.4 million5.1%
Source: Leon Cooperman’s Form 13F for the quarter ended June 30, 2026. Weights calculated from the reported $3.547 billion total.

Vertiv was still by far the top holding, with the number of shares held staying the same. However, its disclosed value increased by 33.6% since March, due to the market price at quarter end—rather than new purchases.

Material disclosed changeJune positionQuarterly share changeReported value
Initiated GPGI position11.38 million sharesNew$180.4 million
Started WhiteHawk Minerals (NYSE:WHK) investment3.26 million sharesNew$90.7 million
GE HealthCare 1.31 million sharesIncrease of 95.4%$83.8 million
Sunoco (NYSE:SUN)225,994 sharesDecrease of 86.1%$15.3 million
Elevance Health ZeroPosition closed$66.7 million at March 31
Atlas Energy Solutions (NYSE:AESI)ZeroExited holding$53.6 million at March 31
Alphabet Class A ZeroPosition exited$21.6 million at March 31
Sources: June and March SEC information tables. Values are quarter-end market values, not transaction proceeds.

The value of the GPGI stake was almost double that of Cooperman’s newly reported holding in WhiteHawk. It was also larger than his reported stakes in Apollo and Mirion. This scale positions GPGI as a major portfolio investment rather than a minor position.

GPGI reported a 4% decline in pro forma second-quarter sales to $473.2 million, with adjusted EBITDA dropping 13% to $113.9 million. CompoSecure performed well, but Husky saw weaker market conditions.

Executive Chairman Dave Cote stated that GPGI reported “second quarter results consistent with our expectations.” He pointed to “record strength” at CompoSecure and described headwinds at Husky as temporary. GPGI second-quarter release

GPGI second-quarter measureQ2 2026Year-on-year change
Pro forma adjusted net sales$473.2 millionDown 4%
Pro forma adjusted EBITDA$113.9 millionDecreased 13%
Pro forma EBITDA margin24.1%230 basis points lower
GAAP net income$50.3 millionNo comparable figure
Adjusted cash and short-term investments$114.8 millionIncreased from $96.5 million
Adjusted total debt$2.115 billionHigher than $192.5 million
Source: GPGI’s August 6 results. Pro forma figures include Husky as if the combination closed January 1, 2025.

Management maintained its full-year pro forma sales outlook between $1.95 billion and $2.10 billion. Adjusted EBITDA is projected in the range of $550 million to $610 million. The company aims for year-end net leverage to be around 3.0 times.

Metal card manufacturer CompoSecure and injection-molding provider Husky have merged under GPGI. The group introduced the new brand in January. Resolute Holdings Management (NYSE:RHLD) oversees the permanent-capital structure.

Analyst recommendation measureLatest available readingImplied move from $12.69
Consensus ratingBuyNot applicable
Analysts included2Certain analysts only
Low target$15+18.2%
Average target$20+57.6%
High target$25+97.0%
Source: S&P Global data via StockAnalysis, last target update May 15, 2026. Implied moves use the August 14 intraday price.

The analyst coverage is limited, with just two analysts forming the consensus, and their targets were set before GPGI’s Q2 results. While Cooperman’s filing introduces a prominent shareholder, it does not provide updated operational outlook.

Risks: Husky could continue to show market weakness. Following the merger, GPGI holds $2.115 billion in adjusted debt. Limited analyst attention and a brief trading record reduce the reliability of valuation estimates.

The 13F provides a retrospective snapshot, listing long U.S. securities as of June 30, while excluding information on transaction dates, cash holdings, and short positions. Cooperman may have altered the GPGI holding following that reporting period.

TS2 TECH • EXTENDED COVERAGE

Further analysis

What information did Leon Cooperman reveal about GPGI shares?
As of June 30, Cooperman held 11,384,508 shares of GPGI valued at $180.4 million. This marked his biggest new position during the second quarter, accounting for 5.1% of his disclosed $3.547 billion U.S. equity holdings.
Does the filing indicate Cooperman acquired GPGI at a price of $15.85?
No. Dividing the $180.4 million quarter-end value by the number of shares gives $15.85 per share, but Form 13F filings do not show the purchase dates or original prices. With a $12.69 intraday price on Friday, those shares were valued around $144.5 million. This difference does not confirm whether Cooperman realized a profit or a loss.
How do GPGI's most recent results affect the investment outlook?
Pro forma sales for the second quarter declined by 4% to $473.2 million, with adjusted EBITDA down 13% at $113.9 million. CompoSecure delivered robust results, whereas Husky encountered challenging market conditions. GPGI reaffirmed its 2026 sales outlook of $1.95 billion to $2.10 billion and its adjusted EBITDA forecast of $550 million to $610 million.
What are the key factors for GPGI investors at this time?
Key factors are Husky execution and lowering debt. GPGI disclosed $2.115 billion in adjusted debt and aims for net leverage of around 3.0 times by year-end. Only two firms currently cover the company, making published price targets particularly uncertain.
Iwona Majkowska

Iwona Majkowska is a financial markets journalist at TS2.tech, specializing in stocks, artificial intelligence and technology. A graduate of the Warsaw School of Economics, she previously worked in equity research and financial analysis before focusing on market reporting. Her daily coverage helps investors follow major developments across U.S. and global markets. Follow Iwona Majkowska on Google News.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

AerCap

NYSE: AER 95 / 100
#2 BUY

Uber

NYSE: UBER 93 / 100
#3 BUY ON WEAKNESS

Taiwan Semiconductor

NYSE: TSM 91 / 100
#4 TACTICAL BUY

dLocal

NASDAQ: DLO 88 / 100
#5 BUY THE RESET

Tapestry

NYSE: TPR 86 / 100
View full portfolio
Editorial model selection. Not personalised advice.
Eton Pharmaceuticals Stock Jumps 38% as Guidance Reset Tests Valuation
Previous Story

Eton Pharmaceuticals Stock Jumps 38% as Guidance Reset Tests Valuation

Capricor Shares Rise with FDA Review of Latest Duchenne Data, Eyes on August 22 Event
Next Story

Capricor Shares Rise with FDA Review of Latest Duchenne Data, Eyes on August 22 Event